DOITU ACNE MICROCRYSTALLINE INVISIBLE ACNE PATCH
US over-the-counter (OTC) label
In the United States, these products are sold as over-the-counter (OTC) drugs: sunscreens, antiperspirants, anti-dandruff products, anticavity toothpastes, acne products and skin protectants. The label separates active and inactive ingredients. In the European Union, a product with a cosmetic purpose must comply with Regulation (EC) No 1223/2009. A filter or active allowed in the United States may not be authorised for that use in the EU. The classification depends on the purpose: a hand sanitiser may fall under biocides and an acne treatment under medicines. This analysis applies the cosmetic rules to the ingredients without establishing the compliance of the finished product. The formula sold in Europe under the same name may be different.
openFDA: US OTC product labels, analysed under European cosmetic rules, retrieved 16 November 2026.
Stated use in the United States
Acne treatment
Published active ingredients
SALIX ALBA (WILLOW) BARK EXTRACT 2% MENTHOL 1.8% BISABOLOL 0.0597% AESCULUS CHINENSIS EXTRACT 0.0078% ZINGIBER OFFICINALE (GINGER) ROOT EXTRACT 0.0003%
Published inactive ingredients
CELLULOSE GUM, POLYISOBUTENE, STYRENE/ISOPRENE COPOLYMER, PICHIA FERMENT LYSATE FILTRATE, CYCLODEXTRIN, SODIUM HYALURONATE
openFDA: US OTC product labels, analysed under European cosmetic rules, retrieved 16 November 2026.
Cosmetic analysis in the European Union
1 ingredient allowed under conditions (maximum concentration, product types): some active ingredient concentrations are printed; the other conditions and the product's classification in the European Union remain to be checked. 11 names recognised out of 11.
SALIX ALBA (WILLOW) BARK EXTRACT 2%, MENTHOL 1.8%, BISABOLOL 0.0597%, AESCULUS CHINENSIS EXTRACT 0.0078%, ZINGIBER OFFICINALE (GINGER) ROOT EXTRACT 0.0003%, CELLULOSE GUM, POLYISOBUTENE, STYRENE/ISOPRENE COPOLYMER, PICHIA FERMENT LYSATE FILTRATE, CYCLODEXTRIN, SODIUM HYALURONATE
Who it concerns
For each group, the ingredients of the list that an official classification or rule mentions. Open an ingredient's page to read what the text says. A group with no name does not mean the ingredients were judged to have no effect for it.
Prohibition or serious classificationThe text prohibits the substance for this use, or ranks it among the most serious hazards (known or presumed carcinogenic, mutagenic or reprotoxic, identified endocrine disruptor).Worth watchingThe text sets a condition or flags a hazard worth knowing: allergen, suspected effect, condition for children, hazard to the aquatic environment.For informationOfficial information with no condition on a finished product: warning to read, irritation of the pure substance.
Skin, eyes and allergies
- Worth watching MENTHOLAllergen to declare: Annex III, entry 338, requires it to be named in the ingredient list above 0.001% in a leave-on product and 0.01% in a rinse-off product, so that allergic people can avoid it.
No official text covers the recognised ingredients for: pregnancy and breastfeeding, babies and children, environment, read on the label.
For a question about your own situation (pregnancy, child, allergy), show this list to your doctor, midwife or pharmacist: we cannot say whether this product suits you.
Selling elsewhere
Ingredients of this list that are prohibited, prohibited in some cases or subject to conditions in the other countries whose rules we record (nothing changes for sale in France). Absence is not approval: several countries only allow the preservatives, UV filters and colorants on their lists, and the function of an ingredient in the product is not known. What is covered for each country.
| Country | Prohibited | Prohibited in some cases | Subject to conditions |
|---|---|---|---|
| Taiwan | - | - | MENTHOL 1.8% |
No prohibition or condition found in the recorded lists for: United Kingdom, United States (federal), Washington State, California, Canada, Japan, South Korea, China, Australia, ASEAN, Brazil.
Ingredient by ingredient
The line under each name gives its rule in the European Union (legend below). Click a name for its page.
Hover over or tap a badge for its meaning.
Classified hazard (cancer, DNA, reproduction): Carcinogenic, mutagenic or toxic for reproduction under the CLPEU regulation that classifies chemicals by their hazards (EC No 1272/2008). Regulation, or identified endocrine disruptor. Irritation, allergy and environment: see “Who it concerns”.
| On the label | Glossary name | Rule in the European Union | Classified hazard (cancer, DNA, reproduction) |
|---|---|---|---|
| SALIX ALBA (WILLOW) BARK EXTRACT 2% | SALIX ALBA BARK EXTRACT Certainty high: name recognised, the brackets add a detail | No specific rule in the Cosmetics Regulation | none |
| MENTHOL 1.8% | MENTHOL | Allowed with restrictions (Annex III) | none |
| BISABOLOL 0.0597% | BISABOLOL | No specific rule in the Cosmetics Regulation | none |
| AESCULUS CHINENSIS EXTRACT 0.0078% | AESCULUS CHINENSIS EXTRACT | No specific rule in the Cosmetics Regulation | none |
| ZINGIBER OFFICINALE (GINGER) ROOT EXTRACT 0.0003% | ZINGIBER OFFICINALE ROOT EXTRACT Certainty high: name recognised, the brackets add a detail | No specific rule in the Cosmetics Regulation | none |
| CELLULOSE GUM | CELLULOSE GUM | No specific rule in the Cosmetics Regulation | none |
| POLYISOBUTENE | POLYISOBUTENE | No specific rule in the Cosmetics Regulation | none |
| STYRENE/ISOPRENE COPOLYMER | STYRENE/ISOPRENE COPOLYMER | No specific rule in the Cosmetics Regulation | none |
| PICHIA FERMENT LYSATE FILTRATE | PICHIA FERMENT LYSATE FILTRATE | No specific rule in the Cosmetics Regulation | none |
| CYCLODEXTRIN | CYCLODEXTRIN | No specific rule in the Cosmetics Regulation | none |
| SODIUM HYALURONATE | SODIUM HYALURONATE | No specific rule in the Cosmetics Regulation | none |
Product record
- Brand or trade name
- DOITU ACNE MICROCRYSTALLINE INVISIBLE ACNE PATCH
- Manufacturer
- GUANGDONG ZHIZHEN BIOLOGICAL MEDICINE CO., LTD.
- Label date
- 24 November 2022
Label in the official openFDA API. This is the label date; the formula may have changed. Compare with the packaging.
List in the official revision dated (register: openFDA: US OTC product labels, analysed under European cosmetic rules).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “DOITU ACNE MICROCRYSTALLINE INVISIBLE ACNE PATCH”, https://compoatlas.com/en/cosmetics/united-states/ee37bbeb-0001-0a8c-e053-2a95a90ade2e-doitu-acne-microcrystalline-invisible-acne-patch, updated 24 November 2022.